CIK 0001585608
- Non-accelerated filer
- Smaller reporting company
Jaguar Health, Inc.
Sign in to watch- Ticker
- JAGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-371-8300
- Business address
- 200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
- Former names
- Jaguar Animal Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-18 | Divis Gregory J Director | Option exercise · Restricted stock units | −12,133 | 0 | ||
| 2022-05-18 | Siegel Jonathan B. Director | Option exercise | +12,133 | 12,133 | ||
| 2022-05-18 | Siegel Jonathan B. Director | Option exercise · Restricted stock units | −12,133 | 0 | ||
| 2022-05-18 | MICEK JOHN Director | Option exercise | +12,133 | 12,133 | ||
| 2022-05-18 | MICEK JOHN Director | Option exercise · Restricted stock units | −12,133 | 0 | ||
| 2022-05-18 | BOCHNOWSKI JAMES J Director | Option exercise | +13,133 | 73,765 | ||
| 2022-05-18 | BOCHNOWSKI JAMES J Director | Option exercise · Restricted stock units | −13,133 | 0 | ||
| 2022-04-05 | Chaturvedi Pravin R Chief Scientific Officer | Option exercise | +10,000 | 10,000 | ||
| 2022-04-05 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award · Restricted stock units | +10,000 | 20,000 | ||
| 2022-04-05 | Chaturvedi Pravin R Chief Scientific Officer | Option exercise | +3,333 | 3,333 | ||
| 2022-04-05 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award · Restricted stock units | +3,333 | 6,666 | ||
| 2022-04-05 | Lizak Carol R. Chief Financial Officer | Option exercise | +4,513 | 12,481 | ||
| 2022-04-05 | Lizak Carol R. Chief Financial Officer | Grant or award · Restricted stock units | +4,513 | 9,028 | ||
| 2022-04-05 | Wolin Jonathan S. Chief of Staff, CCO & GC | Option exercise | +6,666 | 6,666 | ||
| 2022-04-05 | Wolin Jonathan S. Chief of Staff, CCO & GC | Grant or award · Restricted stock units | +6,666 | 13,333 | ||
| 2022-04-05 | King Steven R. Chief of Sustainable Supply | Option exercise | +13,333 | 13,333 | ||
| 2022-04-05 | King Steven R. Chief of Sustainable Supply | Grant or award · Restricted stock units | +13,333 | 26,666 | ||
| 2022-04-05 | CONTE LISA A CEO and President | Option exercise | +45,000 | 53,003 | ||
| 2022-04-05 | CONTE LISA A CEO and President | Grant or award · Restricted stock units | +45,000 | 90,000 | ||
| 2022-03-28 | Divis Gregory J Director | Grant or award · Restricted stock units | +85,900 | 85,900 |
Page 8 of 10 · 185 trades